Analysis of major pathogens, sensitive antibiotics, and related factors in bile from patients with acute biliary pancreatitis
10.3969/j.issn.1673-4130.2019.03.016
- VernacularTitle:急性胆源性胰腺炎患者胆汁中主要致病菌与敏感抗菌药物及相关因素分析
- Author:
Xin CHEN
1
;
Miao NIU
Author Information
1. 解放军210医院检验科
- Keywords:
acute biliary pancreatitis;
drug susceptibility analysis;
antibiotic use
- From:
International Journal of Laboratory Medicine
2019;40(3):321-324
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the main pathogenic bacteria and sensitive antibiotics and related factors in bile in patients with acute biliary pancreatitis (ABP).Methods 176 patients with ABP from September2015 to September 2017 were selected as the study subjects.Bile was collected for bacterial culture and antibiotic susceptibility testing.The relationship between different obstruction sites and total bilirubin levels and bacterial detection rates was compared.Results The positive rate of bacterial culture was 68.18％.There were 155 aerobic bacteria and 25 anaerobic bacteria.Among the G-bacteria, E.coli (62.85％) accounted for the largest proportion, Enterococcus (12.26％) accounted for the highest proportion of G+ bacteria, and Bacteroides fragilis (52.00％) accounted for the majority of anaerobes..The sensitivity of G-bacteria to meropenem, cefepime and ciprofloxacin was greater than 80％, which was 96.77％, 91.13％ and 84.68％, respectively.The sensitivity rate of G+ to vancomycin was 100％, and the sensitivity rate to meropenem, tetracycline, and azithromycin was higher than 80％.The positive rate of bacterial culture in high obstruction was significantly higher than that in middle-low obstruction (P＜0.05).The low-level group was significantly higher than the middle-level group and the high-level group (P＜0.05), and the middle-level group was significantly higher than the high-level group (P＜0.05).Conclusion For the early anti-infection treatment of ABP patients, aminoglycosides+third-generation cefquinolones+ metronidazole can be used for treatment.Patients with high obstruction and low TB levels need to strengthen anti-infection treatment.
